Based on the key indicators related to Affimed NV's liquidity, profitability, solvency, and operating efficiency, Affimed NV is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At present, Affimed NV's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 28.4 M, whereas Total Stockholder Equity is forecasted to decline to about 45.3 M. Key indicators impacting Affimed NV's financial strength include:
Investors should never underestimate Affimed NV's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Affimed NV's cash flow, debt, and profitability to make informed and accurate decisions about investing in Affimed NV.
Net Income
(100.64 Million)
Affimed
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Net Income Per Share
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Cash Ratio
Operating Cash Flow Sales Ratio
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Investments
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Change To Netincome
Change To Liabilities
Other Cashflows From Investing Activities
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Long Term Debt
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Intangible Assets
Common Stock
Property Plant Equipment
Net Tangible Assets
Short Long Term Debt
Short Term Debt
Non Currrent Assets Other
Short Term Investments
Long Term Debt Total
Capital Lease Obligations
Other Current Assets
Long Term Investments
Net Invested Capital
Net Working Capital
Capital Stock
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Net Income From Continuing Ops
Net Income Applicable To Common Shares
Interest Income
Tax Provision
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Affimed NV Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Affimed NV's financial statements are interrelated, with each one affecting the others. For example, an increase in Affimed NV's assets may result in an increase in income on the income statement.
Please note, the presentation of Affimed NV's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Affimed NV's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Affimed NV's management manipulating its earnings.
Affimed NV Stock Summary
Affimed NV competes with Pieris Pharmaceuticals, ADC Therapeutics, Agenus, X4 Pharmaceuticals, and Terns Pharmaceuticals. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Affimed NV's current stock value. Our valuation model uses many indicators to compare Affimed NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Affimed NV competition to find correlations between indicators driving Affimed NV's intrinsic value. More Info.
Affimed NV is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Affimed NV's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Affimed NV by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Affimed NV Systematic Risk
Affimed NV's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Affimed NV volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Affimed NV correlated with the market. If Beta is less than 0 Affimed NV generally moves in the opposite direction as compared to the market. If Affimed NV Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Affimed NV is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Affimed NV is generally in the same direction as the market. If Beta > 1 Affimed NV moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Affimed NV Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Affimed NV's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Affimed NV growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.0436)
At present, Affimed NV's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
Affimed NV November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Affimed NV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Affimed NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Affimed NV based on widely used predictive technical indicators. In general, we focus on analyzing Affimed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Affimed NV's daily price indicators and compare them against related drivers.
When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.